期刊文献+

E-钙黏附蛋白和p120-连环素蛋白在乳腺浸润性小叶癌和导管癌中的表达差异及意义 被引量:4

Expression pattern of E-cadherin and p120-eatenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance
原文传递
导出
摘要 目的比较乳腺浸润性小叶癌(ILC)和浸润性导管癌(IDC)的临床病理学特征,探讨E-钙黏附蛋白(E—cadherin)和p120-连环素蛋白(p120-catenin)在ILC和IDC中的表达差异及意义。方法中国医学科学院肿瘤医院1999年1月至2006年12月共收治ILC123例,2000年收治IDC334例。运用组织微阵列及免疫组织化学染色技术,对123例ILC和334例IDC患者的组织蜡块进行切片,并进行E—cadherin和p120-catenin表达的检测,同时对患者进行随访。结果ILC和IDC患者的5年无瘤生存率(DFS)分别为61.8%和83.7%(P〈0.001),5年总生存率(OS)分别为81.7%和79.1%(P=0.055)。在36例ILC和221例IDC患者中,E—cadherin表达缺失率分别为55.6%(20/36)和20.4%(45/221,P〈0.001),p120-catenin胞浆表达率分别为66.7%(24/36)和16.3%(36/221,P〈0.001)。在ILC患者中,p120-catenin胞浆表达与E—cadherin表达缺失相关(P:0.002)。ILC和IDC患者中,p120-catenin胞浆表达合并E—cadherin表达缺失的比率分别为55.6%(20/36)和4.1%(9/221,P〈0.001)。结论ILC具有不同于1DC的临床病理学特点及预后特征,E-cadherin和p120-catenin的检测有助于ILC和IDC的鉴别诊断。 Objective To determine how patients with infiltrating lobular carcinoma (ILC) differ from patients with the more common infiltrating ductal carcinoma (IDC), and observe the different expression patterns of E-cadherin and p120-catenin proteins in both ILCs and IDCs. Methods The patients with ILC admitted to our hospital from Jan 1999 to Dec 2006 and patients with IDC from Jan 2000 to Dec 2000 were included in this study. All their pathological slides were reviewed, and their clinical data and treatment variables were analyzed retrospectively. Then the expression patterns of E-cadherin and p120-catenin proteins in both ILCs and IDCs were detected by immunohistochemistry on tissue microarray. Results The 5-year overall survival was 81.7% for ILCs and 79. 1% for IDCs (P = 0. 055). The 5-year disease-free survival was 61.8% tor ILCs and 83.7% for IDCs ( P 〈 0. 001 ). Cytoplasmic localization of p120-catenin and loss of E-cadherin expression were more common in ILCs than in IDCs. The complete losses of E- cadherin in ILCs and IDCs were 55.6% (20/36) and 20.4% (45/221, P 〈 0. 001 ), respectively. The p 120-catenin showed a diffuse cytoplasmic localization in 66.7% (24/36) of ILCs and 16.3% (36/221) of IDCs (P 〈 0. 001 ). Interestingly, the cytoplasmic localization of p120-catenin was clearly associated with the absence of E-cadherin expression in ILCs (P = 0. 002) , cytoplasmic localization of p120-catenin and absence of E-cadherin expression were observed 55.6% (20/36) in ILCs compared with 4.1% (9/221) in IDCs (P 〈0. 001 ). Conclusion ILC has several specific biological and prognostic characteristics which are different in IDC. Different expression patterns of E-cadherin and p120-catenin proteins can be helpful to recognize ILC from IDC.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第4期273-277,共5页 Chinese Journal of Oncology
基金 TerryFox基金(LC2006A06)
关键词 乳腺肿瘤 E-钙黏附蛋白 p120-连环素蛋白 预后 Breast neoplasms E-cadherin p120-catenin Prognosis
  • 相关文献

参考文献16

  • 1Tavassoli FA,Devilee P.乳腺及女性生殖器官肿瘤病理学和遗传学.北京:人民卫生出版社,2006.43-44.
  • 2Ashikari R,Huvos AG,Urban JA,et al.Infiltrating lobular carcinoma of the breast.Cancer,1973,31:110-116.
  • 3Toikkanen S,Pylkkanen L,Joensuu H.Invasive lobular carcinoma of the breast has better short-and long-term survival than invasive ductal carcinoma.Br J Cancer,1997,76:1234-1240.
  • 4Sastre-Garau X,Jouve M,Asselain B,et al.Infiltrating lobular carcinoma of the breast:clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.Cancer,1996,77:113-120.
  • 5Arpino G,Bardou VJ,Clark GM,et al.Infiltrating lobular carcinoma of the breast:tumor characteristics and clinical outcome.Breast Cancer Res,2004,6:R149-156.
  • 6Pestalozzi BC,Zahrieh D,Mallon E,et al.Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast:combined results of 15 International Breast Cancer Study Group clinical trials.J Clin Oncol,2008,26:3006-3014.
  • 7阚秀,刘静肾,李红宾.乳腺浸润性小叶癌的组织形态学及其分型[J].诊断病理学杂志,1999,6(1):6-9. 被引量:4
  • 8Cristofanilli M,Gonzalez-Angulo A,Sneige N,et al.Invasive lobular carcinoma classic type:response to primary chemotherapy and survival outcomes.J Clin Oncol,2005,23:41-48.
  • 9苏剑敏,周逸平,徐薇苓,曹立环,查锡良.E-钙粘蛋白在四种肿瘤中表达的比较[J].中华肿瘤杂志,2000,22(3):212-213. 被引量:12
  • 10董慧明,刘刚,吴炅,陆劲松,罗建民,沈镇宙,邵志敏.上皮钙黏着蛋白对人炎性乳腺癌细胞系生物学特性的影响[J].中华肿瘤杂志,2006,28(1):4-7. 被引量:2

二级参考文献15

  • 1Day ML,Zhao X,Vallorosi CJ,et al.E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway.J Biol Chem,1999,274:9656-9664.
  • 2Frixen UH,Behrens J,Sachs M,et al.E-cadherin-mediated cellcell adhesion prevents invasiveness of human carcinoma cells.J Cell Biol,1991,113:173-185.
  • 3Sanceau J,Truchet S,Bauvois B.Matrix metalloproteinase-9silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells.J Biol Chem,2003,278:36537-36546.
  • 4Vleminckx K,Vakaet L Jr,Mareel M,et al.Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.Cell,1991,66:107-119.
  • 5Colpaert CG,Vermeulen PB,Benoy I,et al.Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.Br J Cancer,2003,88:718-725.
  • 6Kleer CG,van Golen KL,Braun T,et al.Persistent E-cadherin expression in inflammatory breast cancer.Mod Pathol,2001,14:458-464.
  • 7Tomlinson JS,Alpaugh ML,Barsky SH.An intact overexpressed Ecadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.Cancer Res,2001,61:5231-5241.
  • 8Alpaugh ML,Tomlinson JS,Shao ZM,et al.A novel human xenograft model of inflammatory breast cancer.Cancer Res,1999,59:5079-5084.
  • 9van Golen KL,Davies S,Wu ZF,et al.A novel putative low-affinity insulin-like growth factor-binding protein,LIBC (lost in inflammatory breast cancer),and RhoC GTPase correlate with the inflammatory breast cancer phenotype.Clin Cancer Res,1999,5:2511-2519.
  • 10Vizirianakis IS,Chen YQ,Kantak SS,et al.Dominant-negative Ecadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.Int J Oncol,2002,21:135-144.

共引文献31

同被引文献36

  • 1Foote FW Jr,Stewart FW.A histologic classification of carcinomaof the breast[J].Surgery,1946,19:74-99.
  • 2Wheeler JE,Enterline HT.Lobular carcinoma of the breast in situand infiltrating[J].Pathol Annu,1976,11:161-188.
  • 3程虹,主译.2003 年WHO乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:19-21.
  • 4Roylance R,Gorman P,Papior T,et al.A comprehensive study ofchromosome 16q in invasive ductal and lobular breast carcinomausing array CGH[J].Oncogene,2006,25(49):6544-6553.
  • 5Rakha EA,Green AR,Powe DG,et al.Chromosome 16 tumor-suppressor genes in breast cancer[J].Genes ChromosomesCancer,2006,45(6):527-535.
  • 6Li CI,Uribe DJ,Daling JR.Clinical characteristics of different histologic types of breast cancer[J].Br J Cancer,2005,93(9):1046-1052.
  • 7Rakha EA,El-Sayed ME,Powe DG,et al.Invasive lobular carcinoma of the breast:Response to hormonal therapy and outcomes[J].Eur J Cancer,2008,44(1):73-83.
  • 8Li CI,Anderson BO,Daling JR,et al.Trends in incidence rates ofinvasive lobular and ductal breastcarcinoma[J].JAMA,2003,289(11):1421-1424.
  • 9Arpino G,Bardou VJ,Clark GM,et al.Infiltrating lobular carcinoma of the breast:Tumor characteristics and clinical outcome[J].Breast Cancer Res,2004,6(3):R149-R156.
  • 10Hwang S,Ioffe O,Lee I,et al.Cytologic diagnosis of invasive lobular carcinoma:factors associated with negative and equivocal diagnoses[J].Diagn Cytopathol,2004,31(2):87-93.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部